Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Thrombocythemia, Essential × Blood Specimen Collection × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Neoplasms 5 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Lung Neoplasms 3 Carcinoma, Hepatocellular 3 Thrombosis 2 Skin Neoplasms 2 Myelodysplastic Syndromes 2 Hodgkin Disease 2 Desmoid Tumors 2 COVID-19 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thymus Neoplasms 1 Testicular Neoplasms 1 Sezary Syndrome 1 Rhabdoid Tumor 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Mesothelioma 1 Meningeal Neoplasms 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1

Interventions

ruxolitinib 3 venetoclax 1 veliparib 1 pevonedistat 1 iadademstat 1 fedratinib 1 decitabine and cedazuridine drug combination 1 bomedemstat 1 Topotecan 1 Specimen Handling 1 Injections 1 INCB057643 1 Decitabine 1 Carboplatin 1 Biopsy 1 Azacitidine 1 Acetylcysteine 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡